Active Ingredient History
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (Phase 2)
Asthma (Phase 2)
Cardiomyopathies (Phase 2)
Cerebellar Diseases (Phase 4)
Colitis, Ulcerative (Phase 2)
COVID-19 (Phase 4)
Crohn Disease (Phase 2)
Demyelinating Diseases (Phase 4)
Fallopian Tube Neoplasms (Phase 1)
Hamartoma (Phase 1)
Healthy Volunteers (Phase 1)
Heart Diseases (Phase 2)
Hepatitis B (Phase 2)
Hepatitis C (Phase 3)
HIV Infections (Phase 3)
HTLV-I Infections (Phase 2)
Lung Diseases (Phase 2/Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Multiple Organ Failure (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Myelitis (Phase 4)
Myelitis, Transverse (Phase 4)
Neuritis (Phase 4)
Optic Neuritis (Phase 4)
Osteopetrosis (Phase 2)
Ovarian Neoplasms (Phase 1)
Paraparesis, Tropical Spastic (Phase 2)
Preventive Medicine (Phase 2)
Psoriasis (Early Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Respiratory Distress Syndrome (Phase 3)
Sarcoma, Kaposi (Phase 1)
Spinal Cord Diseases (Phase 2)
Stroke (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue